KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) EBIT Margin: 2009-2024

Historic EBIT Margin for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to -10.47%.

  • Pacira BioSciences' EBIT Margin rose 8631.00% to 3.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.80%, marking a year-over-year increase of 1514.00%. This contributed to the annual value of -10.47% for FY2024, which is 2346.00% down from last year.
  • Pacira BioSciences' EBIT Margin amounted to -10.47% in FY2024, which was down 180.58% from 12.99% recorded in FY2023.
  • Over the past 5 years, Pacira BioSciences' EBIT Margin peaked at 16.61% during FY2021, and registered a low of -10.47% during FY2024.
  • Over the past 3 years, Pacira BioSciences' median EBIT Margin value was 9.00% (recorded in 2022), while the average stood at 3.84%.
  • Per our database at Business Quant, Pacira BioSciences' EBIT Margin surged by 830bps in 2020 and then tumbled by 2,346bps in 2024.
  • Pacira BioSciences' EBIT Margin (Yearly) stood at 10.79% in 2020, then skyrocketed by 582bps to 16.61% in 2021, then crashed by 760bps to 9.00% in 2022, then spiked by 399bps to 12.99% in 2023, then tumbled by 2,346bps to -10.47% in 2024.